Edluar is licensed for the short-term treatment of insomnia in adults. It is a fast-acting medication that is approved only to treat insomnia that is characterized by difficulty falling asleep, as opposed to difficulty staying asleep. Occasionally, healthcare providers may also recommend Edluar for off-label uses, such as for long-term insomnia treatment.
What Is Edluar Used For?
Edluar® (zolpidem sublingual tablet) is a prescription medication approved for the short-term treatment of insomnia characterized by difficulty falling sleep. It is not approved for other kinds of insomnia, such as that characterized by trouble staying asleep.
What Is Insomnia?
It is not unusual to have trouble sleeping from time to time. However, if you feel that you are not getting enough sleep to adequately function during the day, you could possibly have a sleep disorder called insomnia. Symptoms of insomnia include:
- Frequently having difficulty falling asleep
- Waking up often during the night and having trouble going back to sleep
- Waking up too early in the morning
- Experiencing non-refreshing sleep.
There are several types of insomnia. Each one is often based on how long the insomnia lasts and how often it occurs. These types include:
- Acute insomnia (short-term)
- Transient insomnia (comes and goes)
- Chronic insomnia (long-term).
Short-term insomnia can last from one night to a few weeks. It is often caused by emotional or physical discomfort, and can be related to a single specific event. Insomnia can also be categorized by the specific sleep symptoms that occur (such as difficulty falling asleep versus difficulty staying asleep).
Edluar is fast-acting (and short-acting) and is, therefore, approved only to treat insomnia that is characterized by difficulty falling asleep.
In studies, zolpidem (the active ingredient in Edluar) has been shown to decrease the time it takes to fall asleep for up to 35 days of use; however, it is not clear whether this medication would be effective for a longer period.